JBT Marel Corporation (ICE:JBTM)

Ligand Pharmaceuticals Revenue

JBT Marel had revenue of $934.80M USD in the quarter ending June 30, 2025, with 132.36% growth. This brings the company's revenue in the last twelve months to $2.71B, up 64.98% year-over-year. In the year 2024, JBT Marel had annual revenue of $1.72B with 3.10% growth.

• Revenue (ttm): $2.71B
• Revenue Growth: +64.98%
• P/S Ratio: 2.73
• Revenue / Employee: $222.16K
• Employees: 12,200
• Market Cap: 896.89B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.72B	51.60M	3.10%
Dec 31, 2023	1.66B	74.10M	4.66%
Dec 31, 2022	1.59B	189.50M	13.53%
Dec 31, 2021	1.40B	-327.00M	-18.93%
Dec 31, 2020	1.73B	-217.90M	-11.20%